Is there a bubble in healthcare shares like Cochlear Limited? 

With Australian healthcare heavyweights CSL Limited (ASX:CSL) and Cochlear Limited (ASX:COH) hitting all-time highs, Sydney hedge fund Watermark Funds Management believes the ASX healthcare sector is setting up for a fall. 

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

It is being reported in the Australian Financial Review (AFR) that Watermark Funds Management (Sydney) is taking net short positions against the healthcare sector believing the sector has entered bubble territory.

It is particularly concerned about healthcare stocks with exposure to the US market as funding providers try to rein in costs. So far Australian stocks affected have failed to reflect this in their price unlike their US counterparts. Watermark has estimated that the Australian healthcare sector is up to 65% overpriced compared to its US equivalents.

hc

Source https://www.google.com/finance

Interestingly other fund managers interviewed by the AFR were of a different mindset, believing that although Australia's healthcare companies are expensive they are of a high quality and deserve to trade at a premium.

So who should we believe?

Personally it is hard to argue that the Australian healthcare sector is not expensive compared to the rest of the ASX. The S&P/ASX 200 Health Care Index has grown 18% over the last 12 months compared to the S&P/ASX 200 which is down 2%.

Does this mean the healthcare sector is in bubble territory?

Again this is not a simple question, while it is true Australian healthcare giants such as CSL Limited (ASX: CSL) and Cochlear Limited (ASX: COH) are indeed at all-time highs, both continue to trade very profitably. As an example, while Cochlear is sitting on a price to earnings ratio of around 40, it is forecasting a profit increase for the current financial year of around 30%. This profit forecast was made assuming an exchange rate of 74US cents. If we consider the Australian dollar is already at 72US cents and likely to head lower particularly if the US Federal reserve raises interest rates as predicted in June, then Cochlear's value does not seem as stretched as it may first appear.

Foolish takeaway

While it is interesting to hear the thoughts of various fund managers, their powers of prediction are no better or worse than normal investors. It is also wise to cast a sceptical view on the motives behind making a position known to the market. You only need to cast your mind back 6 months to find the Royal Bank of Scotland was advising its clients to sell everything and warning of a "cataclysmic year". We might wonder how its clients are feeling about that advice now.

Motley Fool contributor Alan Edmunds owns shares of Cochlear Ltd. and CSL Ltd.. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »